FdaApplication
NDA 022512
Identifiers
- fda_app_no: NDA022512
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2010-10-19 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PRADAXA | DABIGATRAN ETEXILATE MESYLATE | EQ 110MG BASE | CAPSULE;ORAL |
| PRADAXA | DABIGATRAN ETEXILATE MESYLATE | EQ 150MG BASE | CAPSULE;ORAL |
| PRADAXA | DABIGATRAN ETEXILATE MESYLATE | EQ 75MG BASE | CAPSULE;ORAL |
3 products